Literature DB >> 23737027

Pregnancy-related characteristics and breast cancer risk.

Theodore M Brasky1, Yanli Li, David J Jaworowicz, Nancy Potischman, Christine B Ambrosone, Alan D Hutson, Jing Nie, Peter G Shields, Maurizio Trevisan, Carole B Rudra, Stephen B Edge, Jo L Freudenheim.   

Abstract

Breast tissues undergo extensive physiologic changes during pregnancy, which may affect breast carcinogenesis. Gestational hypertension, preeclampsia/eclampsia, gestational diabetes, pregnancy weight gain, and nausea and vomiting (N&V) during pregnancy may be indicative of altered hormonal and metabolic profiles and could impact breast cancer risk. Here, we examined associations between these characteristics of a woman's pregnancy and her subsequent breast cancer risk. Participants were parous women that were recruited to a population-based case-control study (Western New York Exposures and Breast Cancer Study). Cases (n = 960), aged 35-79 years, had incident, primary, histologically confirmed breast cancer. Controls (n = 1,852) were randomly selected from motor vehicle records (< 65 years) or Medicare rolls (≥ 65 years). Women were queried on their lifetime pregnancy experiences. Multivariable-adjusted logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). N&V during pregnancy was inversely associated with breast cancer risk. Relative to those who never experienced N&V, ever experiencing N&V was associated with decreased risk (OR 0.69, 95% CI 0.56-0.84) as were increased N&V severity (p trend < 0.001), longer duration (p trend < 0.01), and larger proportion of affected pregnancies (p trend < 0.0001) among women with ≥ 3 pregnancies. Associations were stronger for more recent pregnancies (< 5 years). Findings did not differ by menopausal status or breast cancer subtype including estrogen receptor and HER2 expression status. Other pregnancy characteristics examined were not associated with risk. We observed strong inverse associations between pregnancy N&V and breast cancer risk. Replication of these findings and exploration of underlying mechanisms could provide important insight into breast cancer etiology and prevention.

Entities:  

Mesh:

Year:  2013        PMID: 23737027      PMCID: PMC3737361          DOI: 10.1007/s10552-013-0242-9

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  57 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

2.  Pregnancy hormone metabolite patterns, pregnancy symptoms, and coffee consumption.

Authors:  Christina C Lawson; Grace K LeMasters; Linda S Levin; James H Liu
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897

Review 3.  Reproductive factors and breast cancer.

Authors:  J L Kelsey; M D Gammon; E M John
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

4.  Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.

Authors:  Traci R Lyons; Jenean O'Brien; Virginia F Borges; Matthew W Conklin; Patricia J Keely; Kevin W Eliceiri; Andriy Marusyk; Aik-Choon Tan; Pepper Schedin
Journal:  Nat Med       Date:  2011-08-07       Impact factor: 53.440

5.  Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel.

Authors:  Tal Sella; Gabriel Chodick; Micha Barchana; Anthony D Heymann; Avi Porath; Ehud Kokia; Varda Shalev
Journal:  Cancer Causes Control       Date:  2011-08-17       Impact factor: 2.506

6.  Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Authors:  Stacey A Missmer; A Heather Eliassen; Robert L Barbieri; Susan E Hankinson
Journal:  J Natl Cancer Inst       Date:  2004-12-15       Impact factor: 13.506

Review 7.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

8.  Long-term risk of malignant neoplasm associated with gestational glucose intolerance.

Authors:  Shelagh I Dawson
Journal:  Cancer       Date:  2004-01-01       Impact factor: 6.860

9.  Breast cancer, pregnancy, and breastfeeding.

Authors:  Michael Helewa; Pierre Lévesque; Diane Provencher; Robert H Lea; Vera Rosolowich; Heather M Shapiro
Journal:  J Obstet Gynaecol Can       Date:  2002-02

10.  Endogenous hormones and the aetiology of breast cancer.

Authors:  T J Key; P K Verkasalo
Journal:  Breast Cancer Res       Date:  1999-08-23       Impact factor: 6.466

View more
  13 in total

Review 1.  Reproduction and breast cancer risk.

Authors:  Volker Hanf; Dorothea Hanf
Journal:  Breast Care (Basel)       Date:  2014-12       Impact factor: 2.860

2.  History of Gestational Diabetes Mellitus and Risk of Incident Invasive Breast Cancer among Parous Women in the Nurses' Health Study II Prospective Cohort.

Authors:  Camille E Powe; Deirdre K Tobias; Karin B Michels; Wendy Y Chen; A Heather Eliassen; JoAnn E Manson; Bernard Rosner; Walter C Willett; Frank B Hu; Cuilin Zhang; Janet W Rich-Edwards; Kathryn M Rexrode
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-10-11       Impact factor: 4.254

3.  Gestational diabetes and risk of breast cancer before age 55 years.

Authors:  Kimberly A Bertrand; Katie M O'Brien; Lauren B Wright; Julie R Palmer; William J Blot; A Heather Eliassen; Lynn Rosenberg; Sven Sandin; Deirdre Tobias; Elisabete Weiderpass; Wei Zheng; Anthony J Swerdlow; Minouk J Schoemaker; Hazel B Nichols; Dale P Sandler
Journal:  Int J Epidemiol       Date:  2022-01-06       Impact factor: 7.196

4.  Gestational diabetes and risk of breast cancer before age 55 years.

Authors:  Kimberly A Bertrand; Katie M O'Brien; Lauren B Wright; Julie R Palmer; William J Blot; A Heather Eliassen; Lynn Rosenberg; Sven Sandin; Deirdre Tobias; Elisabete Weiderpass; Wei Zheng; Anthony J Swerdlow; Minouk J Schoemaker; Hazel B Nichols; Dale P Sandler
Journal:  Int J Epidemiol       Date:  2022-01-06       Impact factor: 9.685

5.  Gestational Hypertensive Disorders and Maternal Breast Cancer Risk in a Nationwide Cohort of 40,720 Parous Women.

Authors:  Mandy Goldberg; Mary V Díaz-Santana; Katie M O'Brien; Shanshan Zhao; Clarice R Weinberg; Dale P Sandler
Journal:  Epidemiology       Date:  2022-05-30       Impact factor: 4.860

6.  Hypertensive diseases of pregnancy and risk of breast cancer in the Black Women's Health Study.

Authors:  Zahna Bigham; Yvonne Robles; Karen M Freund; Julie R Palmer; Kimberly A Bertrand
Journal:  Breast Cancer Res Treat       Date:  2022-04-28       Impact factor: 4.624

7.  Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study.

Authors:  Rebecca Troisi; Anne Gulbech Ording; Tom Grotmol; Ingrid Glimelius; Anders Engeland; Mika Gissler; Britton Trabert; Anders Ekbom; Laura Madanat-Harjuoja; Henrik Toft Sørensen; Steinar Tretli; Tone Bjørge
Journal:  Int J Cancer       Date:  2018-08-10       Impact factor: 7.396

Review 8.  Potential Mechanisms underlying the Protective Effect of Pregnancy against Breast Cancer: A Focus on the IGF Pathway.

Authors:  Tiffany A Katz
Journal:  Front Oncol       Date:  2016-10-26       Impact factor: 6.244

9.  Breast cancer risk in relation to history of preeclampsia and hyperemesis gravidarum: Prospective analysis in the Generations Study.

Authors:  Lauren B Wright; Minouk J Schoemaker; Michael E Jones; Alan Ashworth; Anthony J Swerdlow
Journal:  Int J Cancer       Date:  2018-03-23       Impact factor: 7.396

10.  First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants.

Authors:  Lee Ann Prebil; Rochelle R Ereman; Mark J Powell; Farid Jamshidian; Karla Kerlikowske; John A Shepherd; Marc S Hurlbert; Christopher C Benz
Journal:  Cancer Causes Control       Date:  2014-05-07       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.